Markets › LSE › 0ILL.L

Laboratorios Farmaceuticos Rovi, S.A.

LSE:0ILL.LHealthcare

——At close · Market cap — · Next earnings Thu 5 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	52.8%	56.0%	60.7%	58.3%	58.9%	60.7%	—	—
Operating margin	18.5%	28.0%	31.3%	26.5%	23.4%	23.3%	23.3%	+0.0 pts
Net margin	14.5%	23.6%	24.4%	20.5%	17.9%	18.9%	18.9%	+0.0 pts
EBITDA margin	22.2%	31.6%	33.8%	28.7%	27.3%	27.4%	—	—
Return on equity	16.3%	32.5%	38.4%	31.6%	23.9%	21.1%	20.8%	−0.3 pts
Return on assets	10.6%	20.9%	22.7%	21.3%	16.5%	14.7%	14.7%	+0.0 pts
Return on capital employed	17.2%	33.5%	43.8%	36.6%	26.5%	22.4%	—	—
Debt / equity	0.2×	0.2×	0.1×	0.1×	0.2×	0.2×	0.2×	−1.6%
Debt / assets	13.0%	10.0%	8.2%	8.2%	15.2%	15.3%	—	—
Interest coverage	72.4×	200.8×	301.4×	231.5×	76.0×	60.8×	—	—
Current ratio	3.0×	2.7×	2.1×	2.6×	3.1×	3.1×	3.1×	+0.0%
Quick ratio	1.2×	1.4×	1.1×	0.9×	1.0×	1.6×	—	—
Cash ratio	0.4×	0.5×	0.4×	0.1×	0.2×	0.5×	0.5×	+0.0%
Asset turnover	0.7×	0.9×	0.9×	1.0×	0.9×	0.8×	—	—
Inventory turnover	0.9×	1.2×	1.0×	1.0×	1.0×	1.0×	—	—
Receivables turnover	5.0×	4.1×	4.4×	5.8×	5.9×	4.2×	—	—
Dividend payout	15.9%	13.8%	25.5%	40.5%	41.2%	34.1%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.